Research programme: SK potassium channel inhibitors - Acesion Pharma
Alternative Names: NS 309; NS 4591; NS 8593Latest Information Update: 07 Mar 2018
At a glance
- Originator NeuroSearch
- Developer Acesion Pharma; NeuroSearch
- Class Indoles; Oximes; Small molecules
- Mechanism of Action Intermediate conductance calcium activated potassium channel modulators; Small-conductance calcium-activated potassium channel inhibitors; Small-conductance calcium-activated potassium channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Atrial fibrillation
- Discontinued Chronic obstructive pulmonary disease; Epilepsy; Overactive bladder